Format
Items per page
Sort by

Send to:

Choose Destination

Results: 19

1.

Therapeutic efficacy of artemether-lumefantrine on treatment of uncomplicated Plasmodium falciparum mono-infection in an area of high malaria transmission in Zambia.

Hamainza B, Masaninga F, Moonga H, Mwenda M, Chanda-kapata P, Chalwe V, Chanda E, Kamuliwo M, Babaniyi OA.

Malar J. 2014 Nov 17;13:430. doi: 10.1186/1475-2875-13-430.

2.

Efficacy of sulphadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy, Mansa, Zambia.

Tan KR, Katalenich BL, Mace KE, Nambozi M, Taylor SM, Meshnick SR, Wiegand RE, Chalwe V, Filler SJ, Kamuliwo M, Craig AS.

Malar J. 2014 Jun 9;13:227. doi: 10.1186/1475-2875-13-227.

3.

HIV-malaria co-infection: effects of malaria on the prevalence of HIV in East sub-Saharan Africa.

Chalwe V, van Geertruyden JP.

Int J Epidemiol. 2012 Jun;41(3):890-1; author reply 891-2. doi: 10.1093/ije/dys079. Epub 2012 May 21. No abstract available.

4.

A head-to-head comparison of four artemisinin-based combinations for treating uncomplicated malaria in African children: a randomized trial.

Four Artemisinin-Based Combinations (4ABC) Study Group.

PLoS Med. 2011 Nov;8(11):e1001119. doi: 10.1371/journal.pmed.1001119. Epub 2011 Nov 8.

5.

Challenges and prospects for malaria elimination in the Southern Africa region.

Moss WJ, Norris DE, Mharakurwa S, Scott A, Mulenga M, Mason PR, Chipeta J, Thuma PE; Southern Africa ICEMR Team.

Acta Trop. 2012 Mar;121(3):207-11. doi: 10.1016/j.actatropica.2011.06.019. Epub 2011 Aug 19.

6.

Malaria epidemiology and control in Southern Africa.

Mharakurwa S, Thuma PE, Norris DE, Mulenga M, Chalwe V, Chipeta J, Munyati S, Mutambu S, Mason PR; Southern Africa ICEMR Team.

Acta Trop. 2012 Mar;121(3):202-6. doi: 10.1016/j.actatropica.2011.06.012. Epub 2011 Jul 2.

7.

Relative costs and effectiveness of treating uncomplicated malaria in two rural districts in Zambia: implications for nationwide scale-up of home-based management.

Chanda P, Hamainza B, Moonga HB, Chalwe V, Banda P, Pagnoni F.

Malar J. 2011 Jun 9;10:159. doi: 10.1186/1475-2875-10-159.

8.

Community case management of malaria using ACT and RDT in two districts in Zambia: achieving high adherence to test results using community health workers.

Chanda P, Hamainza B, Moonga HB, Chalwe V, Pagnoni F.

Malar J. 2011 Jun 9;10:158. doi: 10.1186/1475-2875-10-158.

9.

Identification of amino acid substitutions associated with neutralization phenotype in the human immunodeficiency virus type-1 subtype C gp120.

Kirchherr JL, Hamilton J, Lu X, Gnanakaran S, Muldoon M, Daniels M, Kasongo W, Chalwe V, Mulenga C, Mwananyanda L, Musonda RM, Yuan X, Montefiori DC, Korber BT, Haynes BF, Gao F.

Virology. 2011 Jan 20;409(2):163-74. doi: 10.1016/j.virol.2010.09.031. Epub 2010 Oct 30.

10.

Increased risk for severe malaria in HIV-1-infected adults, Zambia.

Chalwe V, Van geertruyden JP, Mukwamataba D, Menten J, Kamalamba J, Mulenga M, D'Alessandro U.

Emerg Infect Dis. 2009 May;15(5):749; quiz 858. doi: 10.3201/eid1505.081009.

11.
12.

Effect of presumptive co-trimoxazole prophylaxis on pneumococcal colonization rates, seroepidemiology and antibiotic resistance in Zambian infants: a longitudinal cohort study.

Gill CJ, Mwanakasale V, Fox MP, Chilengi R, Tembo M, Nsofwa M, Chalwe V, Mwananyanda L, Mukwamataba D, Malilwe B, Champo D, Macleod WB, Thea DM, Hamer DH.

Bull World Health Organ. 2008 Dec;86(12):929-38.

13.

Impact of HIV-1 infection on the hematological recovery after clinical malaria.

Van Geertruyden JP, Mulenga M, Chalwe V, Michael N, Moerman F, Mukwamataba D, Colebunders R, D'alessandro U.

J Acquir Immune Defic Syndr. 2009 Feb 1;50(2):200-5. doi: 10.1097/QAI.0b013e3181900159.

PMID:
19131887
14.

Impact of human immunodeficiency virus infection on Streptococcus pneumoniae colonization and seroepidemiology among Zambian women.

Gill CJ, Mwanakasale V, Fox MP, Chilengi R, Tembo M, Nsofwa M, Chalwe V, Mwananyanda L, Mukwamataba D, Malilwe B, Champo D, Macleod WB, Thea DM, Hamer DH.

J Infect Dis. 2008 Apr 1;197(7):1000-5. doi: 10.1086/528806.

15.

Two-dose versus monthly intermittent preventive treatment of malaria with sulfadoxine-pyrimethamine in HIV-seropositive pregnant Zambian women.

Hamer DH, Mwanakasale V, Macleod WB, Chalwe V, Mukwamataba D, Champo D, Mwananyanda L, Chilengi R, Mubikayi L, Mulele CK, Mulenga M, Thea DM, Gill CJ.

J Infect Dis. 2007 Dec 1;196(11):1585-94. Epub 2007 Oct 25.

16.

Inferiority of single-dose sulfadoxine-pyrimethamine intermittent preventive therapy for malaria during pregnancy among HIV-positive Zambian women.

Gill CJ, Macleod WB, Mwanakasale V, Chalwe V, Mwananyanda L, Champo D, Mukwamataba D, Chilengi R, Thea DM, Hamer DH.

J Infect Dis. 2007 Dec 1;196(11):1577-84. Epub 2007 Oct 25.

17.

High throughput functional analysis of HIV-1 env genes without cloning.

Kirchherr JL, Lu X, Kasongo W, Chalwe V, Mwananyanda L, Musonda RM, Xia SM, Scearce RM, Liao HX, Montefiori DC, Haynes BF, Gao F.

J Virol Methods. 2007 Jul;143(1):104-11. Epub 2007 Apr 9.

18.

HIV-1 immune suppression and antimalarial treatment outcome in Zambian adults with uncomplicated malaria.

Van Geertruyden JP, Mulenga M, Mwananyanda L, Chalwe V, Moerman F, Chilengi R, Kasongo W, Van Overmeir C, Dujardin JC, Colebunders R, Kestens L, D'Alessandro U.

J Infect Dis. 2006 Oct 1;194(7):917-25. Epub 2006 Aug 29.

19.

Safety and efficacy of lumefantrine-artemether (Coartem) for the treatment of uncomplicated Plasmodium falciparum malaria in Zambian adults.

Mulenga M, VangGeertruyden JP, Mwananyanda L, Chalwe V, Moerman F, Chilengi R, Van Overmeir C, Dujardin JC, D'Alessandro U.

Malar J. 2006 Aug 21;5:73.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk